Treatment of Dysphagia Using the Mendelsohn Maneuver
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Gastrointestinal |
| Therapuetic Areas: | Gastroenterology, Neurology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 4/17/2018 |
| Start Date: | July 2003 |
| End Date: | September 2008 |
The primary goal of the investigation is to determine the effects of the Mendelsohn maneuver
on the physiology of the swallow in individuals who have suffered a stroke and exhibit signs
of pharyngeal dysphagia.
on the physiology of the swallow in individuals who have suffered a stroke and exhibit signs
of pharyngeal dysphagia.
The primary goal of the investigation is to determine the effects of the Mendelsohn maneuver
(voluntary prolongation of laryngeal excursion at the midpoint of the swallow) on the
physiology of the swallow in individuals who have suffered a stroke and exhibit signs of
pharyngeal dysphagia (specifically, reduced duration of hyoid maximum elevation, reduced
extent of hyoid maximum elevation, reduced duration of hyoid maximum anterior excursion,
reduced extent of hyoid maximum anterior excursion, and reduced duration of upper esophageal
sphincter (UES) opening with subsequent residue in the pyriform sinuses and, potentially,
aspiration). Participants are assessed with videofluoroscopy at the initiation of the study
and after each week of the study. After the 4 weeks of participation are complete, all
participants will be discharged from treatment and will be brought back to the clinic for a
final Videofluoroscopic Swallow Study (VFSS) evaluation after 2 weeks. This means that
individuals in Group 1 will be re-analyzed after 1 month of additional no-treatment, and
Group 2 will be re-analyzed after 2 additional weeks of no-treatment.
(voluntary prolongation of laryngeal excursion at the midpoint of the swallow) on the
physiology of the swallow in individuals who have suffered a stroke and exhibit signs of
pharyngeal dysphagia (specifically, reduced duration of hyoid maximum elevation, reduced
extent of hyoid maximum elevation, reduced duration of hyoid maximum anterior excursion,
reduced extent of hyoid maximum anterior excursion, and reduced duration of upper esophageal
sphincter (UES) opening with subsequent residue in the pyriform sinuses and, potentially,
aspiration). Participants are assessed with videofluoroscopy at the initiation of the study
and after each week of the study. After the 4 weeks of participation are complete, all
participants will be discharged from treatment and will be brought back to the clinic for a
final Videofluoroscopic Swallow Study (VFSS) evaluation after 2 weeks. This means that
individuals in Group 1 will be re-analyzed after 1 month of additional no-treatment, and
Group 2 will be re-analyzed after 2 additional weeks of no-treatment.
Inclusion Criteria:
- Stroke (1-18 months post)
- Pharyngeal Dysphagia
Exclusion Criteria:
- Other neurologic or structural abnormality to oropharynx
- History of dysphagia prior to latest stroke
We found this trial at
1
site
Click here to add this to my saved trials
